Therapeutic uses for Angiotensin-(1-7)

被引：27

作者：

Machado-Silva, Alice ^{[1
]}

Passos-Silva, Danielle ^{[2
]}

Santos, Robson Augusto ^{[2
]}

Sinisterra, Ruben Dario ^{[3
]}

机构：

[1] Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil

[2] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil

[3] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 2016年 / 26卷 / 06期

关键词：

Angiotensin (1-7); Arg0; Mas receptor; PanCyte; TXA-127; RAS; IMPROVES LIPID-METABOLISM; ORAL FORMULATION; SKELETAL-MUSCLE; ENZYME; MAS; SYSTEM; BRAIN; INFLAMMATION; INHIBITION; PEPTIDE;

D O I：

10.1080/13543776.2016.1179283

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Introduction: Angiotensin-(1-7) is a key component of the Renin-Angiotensin System, which can counter-regulate several deleterious effects caused by angiotensin II. Due to the potential for therapeutic use, several of its actions are specifically described in patents. Areas covered: In this review, the authors describe a plethora of therapeutic uses for Angiotensin-(1-7), claimed and supported by experimental evidence in patent documents and applications. Expert opinion: The clinical potential of Angiotensin-(1-7) as a therapeutic agent to treat several pathologies is evidenced by the variety of patents and clinical trials involving this peptide. Cancer treatment is one of the most advanced therapeutic areas, but clinical studies are also available in several other areas, such as cardiovascular, hematological, transplantation, surgical and medical procedures.

引用

页码：669 / 678

页数：10

共 50 条

[1] Angiotensin-(1-7) as a strategy in the treatment of hypertension?
van Twist, Daan J. L.
Kroon, Abraham A.
de Leeuw, Peter W.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (05): : 480 - 486
[2] Angiotensin-(1-7): new perspectives in atherosclerosis treatment
Zhang, Feng
Liu, Jun
Li, Su-Fang
Song, Jun-Xian
Ren, Jing-Yi
Chen, Hong
JOURNAL OF GERIATRIC CARDIOLOGY, 2015, 12 (06) : 676 - 682
[3] Modulation of the action of insulin by angiotensin-(1-7)
Dominici, Fernando P.
Burghi, Valeria
Munoz, Marina C.
Giani, Jorge F.
CLINICAL SCIENCE, 2014, 126 (9-10) : 613 - 630
[4] Angiotensin-(1-7), Adipokines and Inflammation
Lelis, Deborah de Farias
de Freitas, Daniela Fernanda
Machado, Amanda Souto
Crespo, Thaisa Soares
Sousa Santos, Sergio Henrique
METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 95 : 36 - 45
[5] Therapeutic time window for angiotensin-(1-7) in acute lung injury
Supe, Stefanie
Kohse, Franziska
Gembardt, Florian
Kuebler, Wolfgang M.
Walther, Thomas
BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (10) : 1618 - 1628
[6] Angiotensin-(1-7): A novel therapeutic target for preventing cardiovascular disease
Kumar, Gupta Jeetendra
Krishanveer, Singh
Kuldeep, Singh
RESEARCH JOURNAL OF BIOTECHNOLOGY, 2022, 17 (07): : 134 - 143
[7] Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
Kluskens, Leon D.
Nelemans, S. Adriaan
Rink, Rick
de Vries, Louwe
Meter-Arkema, Anita
Wang, Yong
Walther, Thomas
Kuipers, Anneke
Moll, Gert N.
Haas, Marijke
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03): : 849 - 854
[8] Angiotensin-(1-7) inhibits vascular calcification in rats
Sui, Yu-Bin
Chang, Jin-Rui
Chen, Wen-Jia
Zhao, Lei
Zhang, Bao-Hong
Yu, Yan-Rong
Tang, Chao-Shu
Yin, Xin-Hua
Qi, Yong-Fen
PEPTIDES, 2013, 42 : 25 - 34
[9] The therapeutic potential of angiotensin-(1-7) as a novel renin-angiotensin system mediator
Silva, ACE
Pinheiro, SVB
Pereira, RM
Ferreira, AJ
Santos, RAS
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (05) : 603 - 609
[10] Angiotensin-(1-7) mediated calcium signalling by MAS
Sureshkumar, Priyavathi
dos Santos, Robson Augusto Souza
Alenina, Natalia
Mergler, Stefan
Bader, Michael
PEPTIDES, 2023, 165

← 1 2 3 4 5 →